Navigation Links
Drexel University College of Medicine Research May Lead to Improved Alzheimer’s/Vascular Dementia Diagnostic Guidelines

Philadelphia, PA (PRWEB) August 06, 2014

Alzheimer’s disease (AD) and vascular dementia (VaD) are the most common forms of dementia. Traditionally, these illnesses have been treated as separate clinical syndromes. But new research led by Drexel University College of Medicine suggests that AD and VaD have much more in common than diagnostic guidelines currently allow. The study is set for publication in the September edition of the Journal of Alzheimer’s Disease.

The study analyzed 223 patients with dementia, who were seen at an outpatient memory clinic and diagnosed with AD or VaD. Participants were evaluated by a team of dementia specialists and underwent neuropsychological testing, appropriate brain scans, and necessary blood tests.

What the researchers found is that dementia patients thought to be suffering from either AD or VaD could be sorted into distinct, very nuanced clinical profiles. Using latent class analysis, the researchers were able to identify four distinct groups:

  •     Moderate/ mixed dementia group;
  •     Mild/ mixed dementia group;
  •     Dysexecutive group with significant impairment in multi-tasking;
  •     Amnestic group with profound memory loss.
Follow-up analyses comparing these four groups on neuropsychological measures that delved deeper into the process and errors produced on neuropsychological tests showed that the dysexecutive group exhibited marked difficulty sustaining attention and concentration. The moderate/ mixed group evidenced pronounced and greater impairment on language-related tests compared to other neuropsychological abilities. Amnestic patients were clearly distinguished by severe memory problems, but less impaired on other neuropsychological tests. Mild/ mixed patients exhibited milder memory deficits that were intermediary between the amnestic and moderate/mixed groups.

“Through this study we were able to determine that these two common forms of dementia are not wholly separate,” said David J. Libon, PhD, the study’s lead investigator and a professor in the Department of Neurology. “These shared characteristics should be taken into consideration both in the development of future AD and VaD diagnostic guidelines and in selecting patients for newly emerging medicine designed to treat dementia.” Libon went on to say that the heterogeneity seen in this research could be one reason why virtually all clinical trials designed to treat Alzheimer’s disease and related conditions have been so disappointing.

In addition to Dr. Libon, the study’s research team consisted of Deborah Drabick, PhD and Tania Giovannetti, PhD, both from the Department of Psychology at Temple University; Catherine Price, PhD, Department of Clinical and Health Psychology, University of Florida; Mark Bondi, PhD and Lisa Delano-Wood, PhD, both from the Department of Psychiatry, University of California San Diego and the Psychology Service VA San Diego Healthcare System; Melissa Lamar, PhD, Department of Psychiatry, University of Illinois; Daniel Nation, PhD, Department of Psychology, University of Southern California; Rhoda Au, PhD, Department of Neurology, Boston University and the Framingham Heart Study; Rod Swenson, PhD, Department of Neuroscience, North Dakota Medical School; Laura Brennan, PhD, Joel Eppig, BA, and Christine Nieves, BA, all three from the Department of Neurology at Drexel University College of Medicine; and Kathryn Devlin, BA, Department of Psychology at Temple University.

# # #

About Drexel University College of Medicine
Drexel University College of Medicine has established some of the most highly innovative and rigorous academic programs available today, incorporating the University’s expertise in engineering and technology into traditional medical training. The College of Medicine is home to one of the nation’s leading centers for spinal cord research; one of the foremost centers for malaria study; and a highly regarded HIV/AIDS program with extensive NIH-funded research in prevention and therapeutic interventions. Drexel University College of Medicine has been designated a Vanguard National Center of Excellence in Women’s Health by the U.S. Department of Health & Human Services, and is highly respected in numerous other specialties including cardiology and pain management. Visit for more information. Follow Drexel University College of Medicine on Facebook, YouTube, Twitter and Instagram.

Read the full story at

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Abington Memorial Hospital to Become Regional Medical Campus for Drexel University College of Medicine
2. Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine
3. Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells
4. University of Cincinnati researchers win $3.7M grant from US Department of Defense
5. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
6. Rice University student engineers automate limb lengthening for kids
7. Louisiana Tech University professor earns NSF Early Career Development grant
8. Neuropsychologist receives University of Houstons highest faculty honor
9. University of Houston Graduate College of Social Work announces partnership with MD Anderson
10. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
11. University of Minnesota startup to treat challenging bacterial infection
Post Your Comments:
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... , ... October 12, 2017 , ... On Saturday, October ... treadmill relay – Miles by Moonlight to raise money for the American Heart Association ... more. , Teams will work together to keep their treadmills moving for 5 ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE ... team that developed an innovative way to use nonlinear ... the delivery of new drugs. ... Clinical Dermatology Conference will show how researchers from BioPharmX ... Harvard Medical School used a suite of imaging techniques ...
(Date:10/11/2017)... CHICAGO , Oct. 11, 2017  Hill-Rom Holdings, ... its Aspen Surgical facility in Las Piedras, ... surgical scalpels and blades. ... confirmed that the facility sustained minor structural damage, temporary ... Hurricane Maria. Repairs have been completed, manufacturing operations have ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
Breaking Medicine Technology: